Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC01180 is described as a long intergenic non-protein coding RNA, fitting the class of long non-coding RNAs (lncRNAs) which are RNA transcripts longer than 200 nucleotides and not translated into protein[3]. lncRNAs, including those designated as lincRNAs (long intergenic non-coding RNAs), are a broad family of noncoding transcripts that do not overlap protein-coding genes and are noted for a variety of regulatory functions in gene expression and chromatin architecture in some contexts[3][5]. However, *there are no available data or research characterizing the biological function, disease association, or druggability* of LINC01180. No evidence currently supports its use as a therapeutic target, disease biomarker, or its implication in any specific biological pathway. This distinguishes it from other lincRNAs such as LINC01184, which is reported to play a role in colorectal cancer progression[1]. ### Notes on correctness and scope: - There is no evidence that **LINC01180** is a well-characterized gene, nor that it is a therapeutic target, nor that it has ascribed biological or disease functions in major databases or the biomedical literature. Most prominent functional studies pertain to different lincRNAs (notably LINC01184)[1]. Therefore, this entry is marked as *is_incorrect = true* (missing information/likely a placeholder or hypothetical lncRNA name). - The level of available information only supports basic classification: it is an **intergenic lncRNA**, with no evidence for drug interaction, functional role, or association with human disease at this time[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1180 (LINC01180).